Tango Therapeutics Inc (TNGX)
7.61
+0.02
(+0.26%)
USD |
NASDAQ |
May 03, 16:00
7.615
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Profit Margin (Quarterly): -566.4% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -566.4% |
| September 30, 2023 | -207.4% |
| June 30, 2023 | -141.9% |
| March 31, 2023 | -485.7% |
| December 31, 2022 | -453.3% |
| September 30, 2022 | -419.8% |
| June 30, 2022 | -430.7% |
| Date | Value |
|---|---|
| March 31, 2022 | -437.8% |
| December 31, 2021 | -385.7% |
| September 30, 2021 | -288.6% |
| June 30, 2021 | -24.75% |
| March 31, 2021 | -189.6% |
| December 31, 2020 | -96.96% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-566.4%
Minimum
Dec 2023
-24.75%
Maximum
Jun 2021
-317.6%
Average
-385.7%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -61.42% |
| 2seventy bio Inc | -531.8% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.72% |
| Return on Assets | -24.81% |
| Return on Invested Capital | -41.72% |
| Operating Margin (Quarterly) | -644.7% |
| Return on Net Operating Assets | -180.8% |